questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-Serine-Threonine Kinases
Aurora kinases
Aurora kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Kinases Aurora
Diagnostic médical
Marqueurs tumoraux
Kinases Aurora
Cancer du sein
Kinases Aurora
Phosphorylation
Kinases Aurora
Analyse sanguine
Kinases Aurora
Symptômes
5
Symptômes du cancer
Kinases Aurora
Division cellulaire
Kinases Aurora
Signes précoces de cancer
Kinases Aurora
Symptômes neurologiques
Kinases Aurora
Croissance tumorale
Kinases Aurora
Prévention
5
Prévention du cancer
Kinases Aurora
Dépistage du cancer
Kinases Aurora
Mode de vie sain
Kinases Aurora
Antioxydants
Kinases Aurora
Vaccination
Kinases Aurora
Traitements
5
Inhibiteurs de kinases
Kinases Aurora
Efficacité des traitements
Kinases Aurora
Effets secondaires
Kinases Aurora
Chimiothérapie
Kinases Aurora
Essais cliniques
Kinases Aurora
Complications
5
Complications du cancer
Kinases Aurora
Métastases
Kinases Aurora
Pronostic du cancer
Kinases Aurora
Complications des traitements
Kinases Aurora
Réponse immunitaire
Kinases Aurora
Facteurs de risque
5
Facteurs de risque
Kinases Aurora
Alimentation
Kinases Aurora
Infections virales
Kinases Aurora
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Aurora kinases : Questions médicales les plus fréquentes",
"headline": "Aurora kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Aurora kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-30",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Aurora kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protein-Serine-Threonine Kinases",
"url": "https://questionsmedicales.fr/mesh/D017346",
"about": {
"@type": "MedicalCondition",
"name": "Protein-Serine-Threonine Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017346",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aurora kinase A",
"alternateName": "Aurora Kinase A",
"url": "https://questionsmedicales.fr/mesh/D064096",
"about": {
"@type": "MedicalCondition",
"name": "Aurora kinase A",
"code": {
"@type": "MedicalCode",
"code": "D064096",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.103.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aurora kinase B",
"alternateName": "Aurora Kinase B",
"url": "https://questionsmedicales.fr/mesh/D064107",
"about": {
"@type": "MedicalCondition",
"name": "Aurora kinase B",
"code": {
"@type": "MedicalCode",
"code": "D064107",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.103.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aurora kinase C",
"alternateName": "Aurora Kinase C",
"url": "https://questionsmedicales.fr/mesh/D064108",
"about": {
"@type": "MedicalCondition",
"name": "Aurora kinase C",
"code": {
"@type": "MedicalCode",
"code": "D064108",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.103.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Aurora kinases",
"alternateName": "Aurora Kinases",
"code": {
"@type": "MedicalCode",
"code": "D064127",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Karen Schindler",
"url": "https://questionsmedicales.fr/author/Karen%20Schindler",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA."
}
},
{
"@type": "Person",
"name": "Cecilia S Blengini",
"url": "https://questionsmedicales.fr/author/Cecilia%20S%20Blengini",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics; Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America."
}
},
{
"@type": "Person",
"name": "Mansour Aboelenain",
"url": "https://questionsmedicales.fr/author/Mansour%20Aboelenain",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA."
}
},
{
"@type": "Person",
"name": "Jing Wang",
"url": "https://questionsmedicales.fr/author/Jing%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Oncology, the First Affiliated Hospital of Gannan Medical College, Ganzhou, China."
}
},
{
"@type": "Person",
"name": "Tao Guo",
"url": "https://questionsmedicales.fr/author/Tao%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[The virtual ILD board: a pilot project].",
"datePublished": "2023-09-11",
"url": "https://questionsmedicales.fr/article/37696286",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2113-0556"
}
},
{
"@type": "ScholarlyArticle",
"name": "A realist review of dyslexia pilot project research.",
"datePublished": "2023-06-10",
"url": "https://questionsmedicales.fr/article/37300716",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11881-023-00284-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Quality Improvement Pilot Project for Noise Reduction in the NICU.",
"datePublished": "2023-04-05",
"url": "https://questionsmedicales.fr/article/37018178",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ANC.0000000000001074"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suicide Attempt Aftercare in Geriatric Patients: A Pilot Project.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36170052",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01612840.2022.2127039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic Adjunct Techniques in the Assessment of Hypovolemia: A Prospective Pilot Project.",
"datePublished": "2023-09-10",
"url": "https://questionsmedicales.fr/article/37690381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jss.2023.08.005"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Aurora kinases",
"item": "https://questionsmedicales.fr/mesh/D064127"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Aurora kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Aurora kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Aurora kinases",
"description": "Comment diagnostiquer une anomalie des kinases Aurora ?\nQuels marqueurs sont associés aux kinases Aurora ?\nLes kinases Aurora sont-elles liées à des cancers spécifiques ?\nQuels tests sont utilisés pour évaluer l'activité des kinases Aurora ?\nPeut-on détecter les kinases Aurora dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Pilot+Projects#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Aurora kinases",
"description": "Quels symptômes sont liés à une dysrégulation des kinases Aurora ?\nLes kinases Aurora affectent-elles la division cellulaire ?\nY a-t-il des signes précoces de cancer liés aux kinases Aurora ?\nLes kinases Aurora sont-elles impliquées dans des symptômes neurologiques ?\nComment les kinases Aurora influencent-elles la croissance tumorale ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Pilot+Projects#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Aurora kinases",
"description": "Peut-on prévenir les anomalies des kinases Aurora ?\nLes dépistages réguliers aident-ils à détecter les problèmes liés aux kinases Aurora ?\nY a-t-il des facteurs de mode de vie influençant les kinases Aurora ?\nLes antioxydants aident-ils à prévenir les anomalies des kinases Aurora ?\nLes vaccinations peuvent-elles prévenir les cancers liés aux kinases Aurora ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Pilot+Projects#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Aurora kinases",
"description": "Quels traitements ciblent les kinases Aurora ?\nLes inhibiteurs de kinases Aurora sont-ils efficaces ?\nQuels effets secondaires peuvent résulter des traitements ciblant les kinases Aurora ?\nLes traitements ciblant les kinases Aurora sont-ils combinés avec d'autres thérapies ?\nY a-t-il des essais cliniques sur les kinases Aurora ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Pilot+Projects#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Aurora kinases",
"description": "Quelles complications peuvent survenir avec des anomalies des kinases Aurora ?\nLes anomalies des kinases Aurora augmentent-elles le risque de métastases ?\nComment les anomalies des kinases Aurora affectent-elles le pronostic ?\nLes complications des traitements ciblant les kinases Aurora sont-elles fréquentes ?\nLes anomalies des kinases Aurora peuvent-elles affecter la réponse immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Pilot+Projects#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Aurora kinases",
"description": "Quels sont les facteurs de risque associés aux anomalies des kinases Aurora ?\nL'âge influence-t-il le risque d'anomalies des kinases Aurora ?\nLe tabagisme est-il un facteur de risque pour les kinases Aurora ?\nL'alimentation joue-t-elle un rôle dans les anomalies des kinases Aurora ?\nLes infections virales sont-elles liées aux anomalies des kinases Aurora ?",
"url": "https://questionsmedicales.fr/mesh/D064127?mesh_terms=Pilot+Projects#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des kinases Aurora ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de tissus tumoraux peuvent révéler des anomalies."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux kinases Aurora ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux d'expression des kinases Aurora A et B peuvent servir de marqueurs tumoraux."
}
},
{
"@type": "Question",
"name": "Les kinases Aurora sont-elles liées à des cancers spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent surexprimées dans des cancers comme le sein et le poumon."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des kinases Aurora ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de phosphorylation et des analyses de Western blot sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les kinases Aurora dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, la détection se fait principalement dans les tissus tumoraux, pas dans le sang."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysrégulation des kinases Aurora ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon le cancer, mais peuvent inclure fatigue, douleur et perte de poids."
}
},
{
"@type": "Question",
"name": "Les kinases Aurora affectent-elles la division cellulaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles jouent un rôle clé dans la mitose, et leur dysfonction peut entraîner des anomalies cellulaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes précoces de cancer liés aux kinases Aurora ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes précoces peuvent inclure des changements inexpliqués dans le corps, mais sont souvent vagues."
}
},
{
"@type": "Question",
"name": "Les kinases Aurora sont-elles impliquées dans des symptômes neurologiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les kinases Aurora et des troubles neurologiques dans certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les kinases Aurora influencent-elles la croissance tumorale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles régulent la mitose, et leur surexpression peut conduire à une croissance tumorale incontrôlée."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des kinases Aurora ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode spécifique, mais un mode de vie sain peut réduire le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers aident-ils à détecter les problèmes liés aux kinases Aurora ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent aider à détecter des cancers associés aux anomalies des kinases."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs de mode de vie influençant les kinases Aurora ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et l'exercice peuvent influencer la santé cellulaire et réduire les risques."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à prévenir les anomalies des kinases Aurora ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que les antioxydants peuvent réduire le stress oxydatif, mais des recherches sont nécessaires."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir les cancers liés aux kinases Aurora ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancers spécifiques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les kinases Aurora ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques des kinases Aurora sont en développement pour traiter divers cancers."
}
},
{
"@type": "Question",
"name": "Les inhibiteurs de kinases Aurora sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent qu'ils peuvent réduire la croissance tumorale, mais des recherches sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent résulter des traitements ciblant les kinases Aurora ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure nausées, fatigue et troubles hématologiques."
}
},
{
"@type": "Question",
"name": "Les traitements ciblant les kinases Aurora sont-ils combinés avec d'autres thérapies ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent combinés avec la chimiothérapie ou la radiothérapie pour améliorer l'efficacité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques sur les kinases Aurora ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent l'efficacité des inhibiteurs de kinases Aurora dans divers cancers."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies des kinases Aurora ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la progression rapide du cancer et la résistance aux traitements."
}
},
{
"@type": "Question",
"name": "Les anomalies des kinases Aurora augmentent-elles le risque de métastases ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surexpression des kinases Aurora est souvent associée à une augmentation des métastases."
}
},
{
"@type": "Question",
"name": "Comment les anomalies des kinases Aurora affectent-elles le pronostic ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont souvent liées à un pronostic défavorable en raison de la croissance tumorale agressive."
}
},
{
"@type": "Question",
"name": "Les complications des traitements ciblant les kinases Aurora sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme des infections et des troubles sanguins peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les anomalies des kinases Aurora peuvent-elles affecter la réponse immunitaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent altérer la réponse immunitaire, rendant le corps moins efficace contre le cancer."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque associés aux anomalies des kinases Aurora ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux de cancer, l'exposition à des agents cancérigènes."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anomalies des kinases Aurora ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'anomalies des kinases Aurora augmente généralement avec l'âge."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque pour les kinases Aurora ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu pour plusieurs types de cancer associés aux kinases."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les anomalies des kinases Aurora ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en graisses et en sucres peut augmenter le risque de cancer et d'anomalies."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles liées aux anomalies des kinases Aurora ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le HPV, sont associées à des cancers où les kinases Aurora sont impliquées."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA.
Publications dans "Aurora kinases" :
3 publications dans cette catégorie
Affiliations :
Department of Genetics; Rutgers, The State University of New Jersey, Piscataway, New Jersey, United States of America.
Human Genetics Institute of New Jersey; Piscataway, New Jersey, United States of America.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA.
Department of Theriogenology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, the First Affiliated Hospital of Gannan Medical College, Ganzhou, China.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Thoracic surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China. liuq9@mail.sysu.edu.cn.
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China. liuq9@mail.sysu.edu.cn.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Mie University Graduate School of Medicine, Tsu, Mie, 514-8507, Japan.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Chemistry and Quality Assurance, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai 400056, India.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Lanzhou University, Lanzhou 730000, China. Electronic address: chenshw@lzu.edu.cn.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, Seton Hall University, South Orange, NJ, USA.
Department of Genetics, Rutgers University, Piscataway, NJ, USA.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratoire de Spectrométrie de Masse Protéomique, Institute Curie, PSL Research University, Paris, France.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratoire de Spectrométrie de Masse Protéomique, Institute Curie, PSL Research University, Paris, France.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Institut de Génétique et Développement de Rennes (IGDR), Unité CNRS, UMR 6290, Université de Rennes, 35043, Rennes, France.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, All India Institute of Medical Sciences, Delhi 110029, India.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, All India Institute of Medical Sciences, Delhi 110029, India.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, All India Institute of Medical Sciences, Delhi 110029, India. Electronic address: punitkaur@aiims.edu.
Publications dans "Aurora kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, USA.
Publications dans "Aurora kinases" :
Interstitial lung diseases are associated with high morbitity and mortality. Rapid diagnosis in a qualified center is necessary in order to provide the best possible treatment. However, geographic dis...
We conducted a realist review of state-authorized dyslexia pilot projects to understand how they have been implemented and evaluated, and the extent to which they adhere to best practice recommendatio...
Increased noxious noise leads to adverse short-term and long-term effects on the growing neonate. The American Academy of Pediatrics recommends maintaining a noise level of less than 45 decibels (dBA)...
The purpose of this pilot project was to reduce the average noise levels by 39% at the end of an 11-week period....
The location of the project was in a large, high-acuity level IV open-pod layout NICU that consisted of 4 pods, one of which was cardiac-focused. The average baseline noise level in the cardiac pod wa...
At the end of the project, noise levels decreased from 62.6 dBA to 54 dBA, a 13.7% reduction....
At the end of this pilot project it was noted that: Online modules were the best way to educate staff. Parents should be included in the implementation of quality improvement. Healthcare providers nee...
Hospitalized patients after suicide attempts gave informed consent to a postvention project after discharge. A continuous caregiver contacted the subjects monthly by phone for a period of 1 year. In c...
Measuring the hypovolemic resuscitation end point remains a critical care challenge. Our project compared clinical hypovolemia (CH) with three diagnostic adjuncts: 1) noninvasive cardiac output monito...
Adult trauma/surgical intensive care unit patients were prospectively screened for suspected hypovolemia after acute resuscitation, excluding patients with burns, known heart failure, or severe liver/...
44 patients (62% male, median age 60) yielded 65 measures. Positive agreement with CH was 47% for NICOM, 37% for US-IVC and 10% for US-C. None of the three adjuncts correlated with CH (κ -0.045 to 0.0...
None of the adjunct measurements correlated with CH or each other, highlighting that fluid status assessment remains challenging in critical care. US should assess for right ventricular dysfunction pr...
People living with chronic disease should ideally engage with community-based exercise services following hospital-based rehabilitation. However, transition from hospital to community exercise setting...
The aims of this study were to develop and explore the feasibility of a pilot exercise referral pathway between an acute hospital and community gyms for patients with chronic health conditions and to ...
A stakeholder-informed exercise referral pathway was developed and offered to patients following completion of a hospital-based exercise programme for a chronic health condition. The pathway was evalu...
Forty-nine people living with chronic conditions (mean age 72 ± 7.8 years) participated (recruitment rate 59%). The average number of community gym visits over 4 months was 17.4 (range 0-51). Twenty-n...
A structured exercise referral pathway to support exercise transition between hospital and community settings in populations with chronic health conditions appears feasible. Participants reported high...
This manuscript offers findings from a pilot project which prepares nursing students for embodied professional practice through the lens of ethics. Four undergraduate nursing students were mentored by...
Chlamydia disproportionately affects individuals aged 15-24 years. A lack of chlamydia knowledge in this high-risk group likely contributes to decreased testing, but interventions to increase chlamydi...
A pre- and post-test design was used to evaluate participant knowledge of chlamydia before and after completing a nurse-developed web-based education intervention designed for university students....
Forty-seven undergraduate students at one U.S. university participated. A focus group and scientific evidence informed the development of the web-based education....
Participants had a significant increase in chlamydia knowledge after completing the online educational intervention (M = 8.0, SD = 0.000) compared to baseline (M = 6.5, SD = 1.5), t(33) = -5.821, p < ...
In the twenty-first century, health systems have to cope with the challenges posed by their rapidly changing environment. Among these changes, the emergence of digital health solutions is an opportuni...
This study is based on a survey of the dental care provided by three units (Oral Medicine, Periodontology, Orthodontics) of the Department of Community Dentistry, Semmelweis University, Budapest. Duri...
According to our findings, teledentistry has the potential to shorten the visit with an average of 5-10 min per patient, which adds up to 58-116 work hours in a year. If the pilot was rolled out to al...
The rapid development of digital health technologies coupled with the evolving task distribution between health professionals have a great potential to improve health system performance in pursuit of ...
Obesity is a chronic, multifactorial disease which is linked to a number of adverse endocrinological and metabolic conditions. Currently, bariatric surgery is one of the most effective treatments for ...